TY - JOUR AU - Testa, U. AU - Castelli, G. AU - Pelosi, E. PY - 2018 DA - 2018// TI - Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells JO - Cancers UR - https://doi.org/10.3390/cancers10080248 DO - 10.3390/cancers10080248 ID - Testa2018 ER - TY - JOUR AU - Fujii, T. AU - Dracheva, T. AU - Player, A. AU - Chacko, S. AU - Clifford, R. AU - Strausberg, R. L. PY - 2002 DA - 2002// TI - A preliminary transcriptome map of non-small cell lung cancer JO - Can Res VL - 62 ID - Fujii2002 ER - TY - JOUR AU - Rekhtman, N. AU - Ang, D. C. AU - Sima, C. S. AU - Travis, W. D. AU - Moreira, A. L. PY - 2011 DA - 2011// TI - Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens JO - Mod Pathol VL - 24 UR - https://doi.org/10.1038/modpathol.2011.92 DO - 10.1038/modpathol.2011.92 ID - Rekhtman2011 ER - TY - JOUR AU - Righi, L. AU - Graziano, P. AU - Fornari, A. AU - Rossi, G. AU - Barbareschi, M. AU - Cavazza, A. PY - 2011 DA - 2011// TI - Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25830 DO - 10.1002/cncr.25830 ID - Righi2011 ER - TY - JOUR AU - Barlesi, F. AU - Pinot, D. AU - Legoffic, A. AU - Doddoli, C. AU - Chetaille, B. AU - Torre, J. P. PY - 2005 DA - 2005// TI - Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602717 DO - 10.1038/sj.bjc.6602717 ID - Barlesi2005 ER - TY - JOUR AU - Chen, Z. AU - Fillmore, C. M. AU - Hammerman, P. S. AU - Kim, C. F. AU - Wong, K. K. PY - 2014 DA - 2014// TI - Non-small-cell lung cancers: a heterogeneous set of diseases JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3775 DO - 10.1038/nrc3775 ID - Chen2014 ER - TY - JOUR AU - Hanna, J. M. AU - Onaitis, M. W. PY - 2013 DA - 2013// TI - Cell of origin of lung cancer JO - J Carcinog VL - 12 UR - https://doi.org/10.4103/1477-3163.109033 DO - 10.4103/1477-3163.109033 ID - Hanna2013 ER - TY - JOUR AU - Gazdar, A. F. AU - Bunn, P. A. AU - Minna, J. D. PY - 2017 DA - 2017// TI - Small-cell lung cancer: what we know, what we need to know and the path forward JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2017.87 DO - 10.1038/nrc.2017.87 ID - Gazdar2017 ER - TY - JOUR AU - Edwards, B. K. AU - Noone, A. -. M. AU - Mariotto, A. B. AU - Simard, E. P. AU - Boscoe, F. P. AU - Henley, S. J. PY - 2014 DA - 2014// TI - Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28509 DO - 10.1002/cncr.28509 ID - Edwards2014 ER - TY - JOUR AU - Kartal-Yandim, M. AU - Adan-Gokbulut, A. AU - Baran, Y. PY - 2016 DA - 2016// TI - Molecular mechanisms of drug resistance and its reversal in cancer JO - Crit Rev Biotechnol VL - 36 UR - https://doi.org/10.3109/07388551.2015.1015957 DO - 10.3109/07388551.2015.1015957 ID - Kartal-Yandim2016 ER - TY - JOUR AU - Gardner, E. E. AU - Lok, B. H. AU - Schneeberger, V. E. AU - Desmeules, P. AU - Miles, L. A. AU - Arnold, P. K. PY - 2017 DA - 2017// TI - Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis JO - Cancer Cell VL - 31 UR - https://doi.org/10.1016/j.ccell.2017.01.006 DO - 10.1016/j.ccell.2017.01.006 ID - Gardner2017 ER - TY - JOUR AU - Zhang, J. AU - Tian, C. AU - Lv, F. AU - Wang, J. AU - Han, W. AU - Nie, J. PY - 2019 DA - 2019// TI - Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer JO - Cancer Commun (London, England) VL - 39 UR - https://doi.org/10.1186/s40880-019-0363-y DO - 10.1186/s40880-019-0363-y ID - Zhang2019 ER - TY - JOUR AU - Camidge, D. R. AU - Pao, W. AU - Sequist, L. V. PY - 2014 DA - 2014// TI - Acquired resistance to TKIs in solid tumours: learning from lung cancer JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.104 DO - 10.1038/nrclinonc.2014.104 ID - Camidge2014 ER - TY - JOUR AU - Zhang, S. AU - Zhu, L. AU - Xia, B. AU - Chen, E. AU - Zhao, Q. AU - Zhang, X. PY - 2018 DA - 2018// TI - Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study JO - Cancer Commun (London, England) VL - 38 UR - https://doi.org/10.1186/s40880-018-0303-2 DO - 10.1186/s40880-018-0303-2 ID - Zhang2018 ER - TY - JOUR AU - Wang, F. AU - Diao, X. Y. AU - Zhang, X. AU - Shao, Q. AU - Feng, Y. F. AU - An, X. PY - 2019 DA - 2019// TI - Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations JO - Cancer Commun (London, England) VL - 39 UR - https://doi.org/10.1186/s40880-019-0354-z DO - 10.1186/s40880-019-0354-z ID - Wang2019 ER - TY - JOUR AU - Anagnostou, V. AU - Smith, K. N. AU - Forde, P. M. AU - Niknafs, N. AU - Bhattacharya, R. AU - White, J. PY - 2017 DA - 2017// TI - Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-0828 DO - 10.1158/2159-8290.CD-16-0828 ID - Anagnostou2017 ER - TY - JOUR AU - Shibue, T. AU - Weinberg, R. A. PY - 2017 DA - 2017// TI - EMT, CSCs, and drug resistance: the mechanistic link and clinical implications JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2017.44 DO - 10.1038/nrclinonc.2017.44 ID - Shibue2017 ER - TY - JOUR AU - Batlle, E. AU - Clevers, H. PY - 2017 DA - 2017// TI - Cancer stem cells revisited JO - Nat Med VL - 23 UR - https://doi.org/10.1038/nm.4409 DO - 10.1038/nm.4409 ID - Batlle2017 ER - TY - JOUR AU - Pattabiraman, D. R. AU - Weinberg, R. A. PY - 2014 DA - 2014// TI - Tackling the cancer stem cells—what challenges do they pose? JO - Nat Rev Drug Discov VL - 13 UR - https://doi.org/10.1038/nrd4253 DO - 10.1038/nrd4253 ID - Pattabiraman2014 ER - TY - JOUR AU - Scheel, C. AU - Eaton, E. N. AU - Li, S. H. AU - Chaffer, C. L. AU - Reinhardt, F. AU - Kah, K. J. PY - 2011 DA - 2011// TI - Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast JO - Cell VL - 145 UR - https://doi.org/10.1016/j.cell.2011.04.029 DO - 10.1016/j.cell.2011.04.029 ID - Scheel2011 ER - TY - JOUR AU - Larsen, T. V. AU - Hussmann, D. AU - Nielsen, A. L. PY - 2019 DA - 2019// TI - PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer JO - Cancer Commun (London, England) VL - 39 UR - https://doi.org/10.1186/s40880-019-0376-6 DO - 10.1186/s40880-019-0376-6 ID - Larsen2019 ER - TY - JOUR AU - Brabletz, T. AU - Kalluri, R. AU - Nieto, M. A. AU - Weinberg, R. A. PY - 2018 DA - 2018// TI - EMT in cancer JO - Nat Rev Cancer VL - 18 UR - https://doi.org/10.1038/nrc.2017.118 DO - 10.1038/nrc.2017.118 ID - Brabletz2018 ER - TY - JOUR AU - Suda, K. AU - Rozeboom, L. AU - Rivard, C. J. AU - Yu, H. AU - Ellison, K. AU - Melnick, M. A. C. PY - 2017 DA - 2017// TI - Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells JO - Lung Cancer (Amsterdam, Netherlands) VL - 109 UR - https://doi.org/10.1016/j.lungcan.2017.04.010 DO - 10.1016/j.lungcan.2017.04.010 ID - Suda2017 ER - TY - JOUR AU - Hou, S. AU - Han, X. AU - Ji, H. PY - 2016 DA - 2016// TI - Squamous transition of lung adenocarcinoma and drug resistance JO - Trends Cancer VL - 2 UR - https://doi.org/10.1016/j.trecan.2016.08.002 DO - 10.1016/j.trecan.2016.08.002 ID - Hou2016 ER - TY - JOUR AU - Niederst, M. J. AU - Sequist, L. V. AU - Poirier, J. T. AU - Mermel, C. H. AU - Lockerman, E. L. AU - Garcia, A. R. PY - 2015 DA - 2015// TI - RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms7377 DO - 10.1038/ncomms7377 ID - Niederst2015 ER - TY - JOUR AU - Deng, P. AU - Hu, C. AU - Zhou, L. AU - Li, Y. AU - Huang, L. PY - 2013 DA - 2013// TI - Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer JO - Mol Clin Oncol VL - 1 UR - https://doi.org/10.3892/mco.2013.137 DO - 10.3892/mco.2013.137 ID - Deng2013 ER - TY - JOUR AU - Ruffini, E. AU - Rena, O. AU - Oliaro, A. AU - Filosso, P. L. AU - Bongiovanni, M. AU - Arslanian, A. PY - 2002 DA - 2002// TI - Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance JO - Eur J Cardiothorac Surg VL - 22 UR - https://doi.org/10.1016/S1010-7940(02)00481-5 DO - 10.1016/S1010-7940(02)00481-5 ID - Ruffini2002 ER - TY - JOUR AU - Ahmed, T. AU - Vial, M. R. AU - Ost, D. AU - Stewart, J. AU - Hasan, M. A. AU - Grosu, H. B. PY - 2018 DA - 2018// TI - Non-small cell lung cancer transdifferentiation into small cell lung cancer: a case series JO - Lung Cancer (Amsterdam, Netherlands) VL - 122 UR - https://doi.org/10.1016/j.lungcan.2018.06.024 DO - 10.1016/j.lungcan.2018.06.024 ID - Ahmed2018 ER - TY - JOUR AU - Wagner, P. L. AU - Kitabayashi, N. AU - Chen, Y. T. AU - Saqi, A. PY - 2009 DA - 2009// TI - Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components JO - Am J Clin Pathol VL - 131 UR - https://doi.org/10.1309/ajcpynpfl56pozqy DO - 10.1309/ajcpynpfl56pozqy ID - Wagner2009 ER - TY - JOUR AU - Siegele, B. J. AU - Shilo, K. AU - Chao, B. H. AU - Carbone, D. AU - Zhao, W. AU - Ioffe, O. PY - 2016 DA - 2016// TI - Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: two cases and a review of the literature JO - Lung Cancer (Amsterdam, Netherlands) VL - 95 UR - https://doi.org/10.1016/j.lungcan.2016.02.012 DO - 10.1016/j.lungcan.2016.02.012 ID - Siegele2016 ER - TY - JOUR AU - Zakowski, M. F. AU - Ladanyi, M. AU - Kris, M. G. PY - 2006 DA - 2006// TI - EGFR mutations in small-cell lung cancers in patients who have never smoked JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMc053610 DO - 10.1056/NEJMc053610 ID - Zakowski2006 ER - TY - JOUR AU - Sequist, L. V. AU - Waltman, B. A. AU - Dias-Santagata, D. AU - Digumarthy, S. AU - Turke, A. B. AU - Fidias, P. PY - 2011 DA - 2011// TI - Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002003 DO - 10.1126/scitranslmed.3002003 ID - Sequist2011 ER - TY - JOUR AU - Cha, Y. J. AU - Cho, B. C. AU - Kim, H. R. AU - Lee, H. -. J. AU - Shim, H. S. PY - 2016 DA - 2016// TI - A case of ALK-rearranged adenocarcinoma with small cell carcinoma-like transformation and resistance to crizotinib JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.12.097 DO - 10.1016/j.jtho.2015.12.097 ID - Cha2016 ER - TY - JOUR AU - Fujita, S. AU - Masago, K. AU - Katakami, N. AU - Yatabe, Y. PY - 2016 DA - 2016// TI - Transformation to SCLC after treatment with the ALK inhibitor alectinib JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.12.105 DO - 10.1016/j.jtho.2015.12.105 ID - Fujita2016 ER - TY - JOUR AU - Araki, J. AU - Okamoto, I. AU - Suto, R. AU - Ichikawa, Y. AU - Sasaki, J. PY - 2005 DA - 2005// TI - Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer JO - Lung cancer (Amsterdam, Netherlands) VL - 48 UR - https://doi.org/10.1016/j.lungcan.2004.10.012 DO - 10.1016/j.lungcan.2004.10.012 ID - Araki2005 ER - TY - JOUR AU - Oser, M. G. AU - Niederst, M. J. AU - Sequist, L. V. AU - Engelman, J. A. PY - 2015 DA - 2015// TI - Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/s1470-2045(14)71180-5 DO - 10.1016/s1470-2045(14)71180-5 ID - Oser2015 ER - TY - JOUR AU - George, J. AU - Lim, J. S. AU - Jang, S. J. AU - Cun, Y. AU - Ozretic, L. AU - Kong, G. PY - 2015 DA - 2015// TI - Comprehensive genomic profiles of small cell lung cancer JO - Nature VL - 524 UR - https://doi.org/10.1038/nature14664 DO - 10.1038/nature14664 ID - George2015 ER - TY - JOUR AU - Park, J. W. AU - Lee, J. K. AU - Sheu, K. M. AU - Wang, L. AU - Balanis, N. G. AU - Nguyen, K. PY - 2018 DA - 2018// TI - Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage JO - Science VL - 362 UR - https://doi.org/10.1126/science.aat5749 DO - 10.1126/science.aat5749 ID - Park2018 ER - TY - BOOK AU - Travis, W. D. AU - Brambilla, E. AU - Burke, A. P. AU - Marx, A. AU - Nicholson, A. G. PY - 2015 DA - 2015// TI - WHO classification of tumours of the lung, pleura, thymus and heart PB - International Agency for Research on Cancer CY - Lyon ID - Travis2015 ER - TY - JOUR AU - Niho, S. AU - Yokose, T. AU - Kodama, T. AU - Nishiwaki, Y. AU - Mukai, K. PY - 1999 DA - 1999// TI - Clonal analysis of adenosquamous carcinoma of the lung JO - Jpn J Cancer Res VL - 90 UR - https://doi.org/10.1111/j.1349-7006.1999.tb00703.x DO - 10.1111/j.1349-7006.1999.tb00703.x ID - Niho1999 ER - TY - JOUR AU - Kang, S. M. AU - Kang, H. J. AU - Shin, J. H. AU - Kim, H. AU - Shin, D. H. AU - Kim, S. K. PY - 2007 DA - 2007// TI - Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22413 DO - 10.1002/cncr.22413 ID - Kang2007 ER - TY - JOUR AU - Jia, X. -. L. AU - Chen, G. PY - 2011 DA - 2011// TI - EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung JO - Lung Cancer (Amsterdam, Netherlands). VL - 74 UR - https://doi.org/10.1016/j.lungcan.2011.04.005 DO - 10.1016/j.lungcan.2011.04.005 ID - Jia2011 ER - TY - JOUR AU - Tochigi, N. AU - Dacic, S. AU - Nikiforova, M. AU - Cieply, K. M. AU - Yousem, S. A. PY - 2011 DA - 2011// TI - Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population JO - Am J Clin Pathol VL - 135 UR - https://doi.org/10.1309/AJCP08IQZAOGYLFL DO - 10.1309/AJCP08IQZAOGYLFL ID - Tochigi2011 ER - TY - JOUR AU - Han, X. AU - Li, F. AU - Fang, Z. AU - Gao, Y. AU - Li, F. AU - Fang, R. PY - 2014 DA - 2014// TI - Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4261 DO - 10.1038/ncomms4261 ID - Han2014 ER - TY - JOUR AU - Zhang, H. AU - Fillmore Brainson, C. AU - Koyama, S. AU - Redig, A. J. AU - Chen, T. AU - Li, S. PY - 2017 DA - 2017// TI - Lkb1 inactivation drives lung cancer lineage switching governed by polycomb repressive complex 2 JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms14922 DO - 10.1038/ncomms14922 ID - Zhang2017 ER - TY - JOUR AU - Ji, H. AU - Ramsey, M. R. AU - Hayes, D. N. AU - Fan, C. AU - McNamara, K. AU - Kozlowski, P. PY - 2007 DA - 2007// TI - LKB1 modulates lung cancer differentiation and metastasis JO - Nature VL - 448 UR - https://doi.org/10.1038/nature06030 DO - 10.1038/nature06030 ID - Ji2007 ER - TY - JOUR AU - Sanchez-Cespedes, M. AU - Parrella, P. AU - Esteller, M. AU - Nomoto, S. AU - Trink, B. AU - Engles, J. M. PY - 2002 DA - 2002// TI - Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung JO - Cancer Res VL - 62 ID - Sanchez-Cespedes2002 ER - TY - JOUR AU - Gao, Y. AU - Xiao, Q. AU - Ma, H. AU - Li, L. AU - Liu, J. AU - Feng, Y. PY - 2010 DA - 2010// TI - LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling JO - Proc Natl Acad Sci USA VL - 107 UR - https://doi.org/10.1073/pnas.1004952107 DO - 10.1073/pnas.1004952107 ID - Gao2010 ER - TY - JOUR AU - Li, F. AU - Han, X. AU - Li, F. AU - Wang, R. AU - Wang, H. AU - Gao, Y. PY - 2015 DA - 2015// TI - LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.04.001 DO - 10.1016/j.ccell.2015.04.001 ID - Li2015 ER - TY - JOUR AU - Gao, Y. AU - Zhang, W. AU - Han, X. AU - Li, F. AU - Wang, X. AU - Wang, R. PY - 2014 DA - 2014// TI - YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms5629 DO - 10.1038/ncomms5629 ID - Gao2014 ER - TY - JOUR AU - Wang, T. -. H. AU - Hsia, S. -. M. AU - Shieh, T. -. M. PY - 2016 DA - 2016// TI - Lysyl oxidase and the tumor microenvironment JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18010062 DO - 10.3390/ijms18010062 ID - Wang2016 ER - TY - JOUR AU - Yao, S. AU - Han, X. AU - Tong, X. AU - Li, F. AU - Qin, Z. AU - Huang, H. -. Y. PY - 2018 DA - 2018// TI - Lysyl oxidase inhibition drives the transdifferentiation from lung adenocarcinoma to squamous cell carcinoma in mice JO - bioRxiv UR - https://doi.org/10.1101/314393 DO - 10.1101/314393 ID - Yao2018 ER - TY - JOUR AU - Shen, X. AU - Liu, Y. AU - Hsu, Y. J. AU - Fujiwara, Y. AU - Kim, J. AU - Mao, X. PY - 2008 DA - 2008// TI - EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency JO - Mol Cell VL - 32 UR - https://doi.org/10.1016/j.molcel.2008.10.016 DO - 10.1016/j.molcel.2008.10.016 ID - Shen2008 ER - TY - JOUR AU - Mukhopadhyay, A. AU - Berrett, K. C. AU - Kc, U. AU - Clair, P. M. AU - Pop, S. M. AU - Carr, S. R. PY - 2014 DA - 2014// TI - Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer JO - Cell Rep VL - 8 UR - https://doi.org/10.1016/j.celrep.2014.05.036 DO - 10.1016/j.celrep.2014.05.036 ID - Mukhopadhyay2014 ER - TY - JOUR AU - Camolotto, S. A. AU - Pattabiraman, S. AU - Mosbruger, T. L. AU - Jones, A. AU - Belova, V. K. AU - Orstad, G. PY - 2018 DA - 2018// TI - FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer JO - eLife UR - https://doi.org/10.7554/elife.38579 DO - 10.7554/elife.38579 ID - Camolotto2018 ER - TY - JOUR AU - Liu, Q. AU - Liu, K. AU - Cui, G. AU - Huang, X. AU - Yao, S. AU - Guo, W. PY - 2019 DA - 2019// TI - Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction JO - Nat Genet VL - 51 UR - https://doi.org/10.1038/s41588-019-0346-6 DO - 10.1038/s41588-019-0346-6 ID - Liu2019 ER - TY - JOUR AU - Wang, Z. AU - Shen, Z. AU - Li, Z. AU - Duan, J. AU - Fu, S. AU - Liu, Z. PY - 2015 DA - 2015// TI - Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations JO - Proc Natl Acad Sci USA VL - 112 UR - https://doi.org/10.1073/pnas.1510837112 DO - 10.1073/pnas.1510837112 ID - Wang2015 ER - TY - JOUR AU - Wang, Y. AU - Dong, Q. AU - Zhang, Q. AU - Li, Z. AU - Wang, E. AU - Qiu, X. PY - 2010 DA - 2010// TI - Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer JO - Cancer Sci VL - 101 UR - https://doi.org/10.1111/j.1349-7006.2010.01511.x DO - 10.1111/j.1349-7006.2010.01511.x ID - Wang2010 ER - TY - JOUR AU - Zhang, W. AU - Gao, Y. AU - Li, F. AU - Tong, X. AU - Ren, Y. AU - Han, X. PY - 2015 DA - 2015// TI - YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-3396 DO - 10.1158/0008-5472.CAN-14-3396 ID - Zhang2015 ER - TY - JOUR AU - Huang, H. AU - Zhang, W. AU - Pan, Y. AU - Gao, Y. AU - Deng, L. AU - Li, F. PY - 2017 DA - 2017// TI - YAP suppresses lung squamous cell carcinoma progression via deregulation of the DNp63-GPX2 axis and ROS accumulation JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-17-0449 DO - 10.1158/0008-5472.CAN-17-0449 ID - Huang2017 ER - TY - JOUR AU - Yao, Y. AU - Zhu, Z. AU - Wu, Y. AU - Chai, Y. PY - 2018 DA - 2018// TI - Histologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: a case report JO - Medicine VL - 97 UR - https://doi.org/10.1097/md.0000000000010650 DO - 10.1097/md.0000000000010650 ID - Yao2018 ER - TY - JOUR AU - Jiang, M. AU - Zhu, X. AU - Han, X. AU - Jing, H. AU - Han, T. AU - Li, Q. PY - 2019 DA - 2019// TI - Histologic transformation of non-small-cell lung cancer in brain metastases JO - Int J Clin Oncol VL - 24 UR - https://doi.org/10.1007/s10147-018-1369-1 DO - 10.1007/s10147-018-1369-1 ID - Jiang2019 ER - TY - JOUR AU - Kogo, M. AU - Shimizu, R. AU - Uehara, K. AU - Takahashi, Y. AU - Kokubo, M. AU - Imai, Y. PY - 2015 DA - 2015// TI - Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor JO - Lung Cancer (Amsterdam, Netherlands) VL - 90 UR - https://doi.org/10.1016/j.lungcan.2015.09.002 DO - 10.1016/j.lungcan.2015.09.002 ID - Kogo2015 ER - TY - JOUR AU - Moriya, R. AU - Hokari, S. AU - Shibata, S. AU - Koizumi, T. AU - Tetsuka, T. AU - Ito, K. PY - 2017 DA - 2017// TI - Histological transformation to large cell neuroendocrine carcinoma from lung adenocarcinoma harboring an EGFR mutation: an autopsy case report JO - Intern Med VL - 56 UR - https://doi.org/10.2169/internalmedicine.56.7452 DO - 10.2169/internalmedicine.56.7452 ID - Moriya2017 ER - TY - JOUR AU - Kang, D. B. AU - Oh, J. T. AU - Jo, H. J. AU - Park, W. C. PY - 2011 DA - 2011// TI - Primary adenosquamous carcinoma of the colon JO - J Korean Surg Soc VL - 80 UR - https://doi.org/10.4174/jkss.2011.80.Suppl1.S31 DO - 10.4174/jkss.2011.80.Suppl1.S31 ID - Kang2011 ER - TY - JOUR AU - Bassler, T. J. AU - Orozco, R. AU - Bassler, I. C. AU - Boyle, L. M. AU - Bormes, T. PY - 1999 DA - 1999// TI - Adenosquamous carcinoma of the prostate: case report with DNA analysis, immunohistochemistry, and literature review JO - Urology VL - 53 UR - https://doi.org/10.1016/S0090-4295(98)00418-X DO - 10.1016/S0090-4295(98)00418-X ID - Bassler1999 ER - TY - JOUR AU - Baydar, D. E. AU - Kosemehmetoglu, K. AU - Akdogan, B. AU - Ozen, H. PY - 2006 DA - 2006// TI - Prostatic adenosquamous carcinoma metastasizing to testis JO - Sci World J VL - 6 UR - https://doi.org/10.1100/tsw.2006.388 DO - 10.1100/tsw.2006.388 ID - Baydar2006 ER - TY - JOUR AU - Gattuso, P. AU - Carson, H. J. AU - Candel, A. AU - Castelli, M. J. PY - 1995 DA - 1995// TI - Adenosquamous carcinoma of the prostate JO - Hum Pathol VL - 26 UR - https://doi.org/10.1016/0046-8177(95)90125-6 DO - 10.1016/0046-8177(95)90125-6 ID - Gattuso1995 ER - TY - JOUR AU - Accetta, P. A. AU - Gardner, W. A. PY - 1983 DA - 1983// TI - Adenosquamous carcinoma of prostate JO - Urology VL - 22 UR - https://doi.org/10.1016/0090-4295(83)90355-2 DO - 10.1016/0090-4295(83)90355-2 ID - Accetta1983 ER - TY - JOUR AU - Devaney, D. M. AU - Dorman, A. AU - Leader, M. PY - 1991 DA - 1991// TI - Adenosquamous carcinoma of the prostate: a case report JO - Hum Pathol VL - 22 UR - https://doi.org/10.1016/0046-8177(91)90014-G DO - 10.1016/0046-8177(91)90014-G ID - Devaney1991 ER - TY - JOUR AU - Egilmez, T. AU - Bal, N. AU - Guvel, S. AU - Kilinc, F. AU - Ozkardes, H. PY - 2005 DA - 2005// TI - Adenosquamous carcinoma of the prostate JO - Int J Urol VL - 12 UR - https://doi.org/10.1111/j.1442-2042.2005.01036.x DO - 10.1111/j.1442-2042.2005.01036.x ID - Egilmez2005 ER - TY - JOUR AU - Humphrey, P. A. PY - 2012 DA - 2012// TI - Histological variants of prostatic carcinoma and their significance JO - Histopathology VL - 60 UR - https://doi.org/10.1111/j.1365-2559.2011.04039.x DO - 10.1111/j.1365-2559.2011.04039.x ID - Humphrey2012 ER - TY - JOUR AU - Ishigooka, M. AU - Yaguchi, H. AU - Tomaru, M. AU - Sasagawa, I. AU - Nakada, T. AU - Mitobe, K. PY - 1994 DA - 1994// TI - Mixed prostatic carcinoma containing malignant squamous element. Reports of two cases JO - Scand J Urol Nephrol VL - 28 UR - https://doi.org/10.3109/00365599409180526 DO - 10.3109/00365599409180526 ID - Ishigooka1994 ER - TY - JOUR AU - Mishra, S. AU - Goel, H. AU - Awasthi, N. AU - Puri, A. AU - Mahapatra, R. AU - Pal, D. K. PY - 2014 DA - 2014// TI - Primary adenosquamous carcinoma of the prostate: a rare aggressive tumor JO - Clin Genitourin Cancer VL - 12 UR - https://doi.org/10.1016/j.clgc.2013.08.006 DO - 10.1016/j.clgc.2013.08.006 ID - Mishra2014 ER - TY - JOUR AU - Moyana, T. N. PY - 1987 DA - 1987// TI - Adenosquamous carcinoma of the prostate JO - Am J Surg Pathol VL - 11 UR - https://doi.org/10.1097/00000478-198705000-00010 DO - 10.1097/00000478-198705000-00010 ID - Moyana1987 ER - TY - JOUR AU - Orhan, D. AU - Sak, S. D. AU - Yaman, O. AU - Tulunay, O. AU - Gogus, O. PY - 1996 DA - 1996// TI - Adenosquamous carcinoma of the prostate JO - Br J Urol VL - 78 UR - https://doi.org/10.1046/j.1464-410X.1996.20830.x DO - 10.1046/j.1464-410X.1996.20830.x ID - Orhan1996 ER - TY - JOUR AU - Regi, P. AU - Butturini, G. AU - Malleo, G. AU - Pedica, F. AU - D’Onofrio, M. AU - Bassi, C. PY - 2011 DA - 2011// TI - Clinicopathological features of adenosquamous pancreatic cancer JO - Langenbeck’s Arch Surg VL - 396 UR - https://doi.org/10.1007/s00423-010-0677-3 DO - 10.1007/s00423-010-0677-3 ID - Regi2011 ER - TY - JOUR AU - Somerville, T. D. D. AU - Xu, Y. AU - Miyabayashi, K. AU - Tiriac, H. AU - Cleary, C. R. AU - Maia-Silva, D. PY - 2018 DA - 2018// TI - TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma JO - Cell Rep VL - 25 UR - https://doi.org/10.1016/j.celrep.2018.10.051 DO - 10.1016/j.celrep.2018.10.051 ID - Somerville2018 ER - TY - JOUR AU - Harada, T. AU - Shimaoka, K. AU - Yakumaru, K. AU - Ito, K. PY - 1982 DA - 1982// TI - Squamous cell carcinoma of the thyroid gland—transition from adenocarcinoma JO - J Surg Oncol VL - 19 UR - https://doi.org/10.1002/jso.2930190111 DO - 10.1002/jso.2930190111 ID - Harada1982 ER - TY - JOUR AU - Rausch, T. AU - Benhattar, J. AU - Sutter, M. AU - Andrejevic-Blant, S. PY - 2010 DA - 2010// TI - Thyroid carcinoma with papillary and squamous features: report of a case with histogenetic considerations JO - Pathol Res Pract VL - 206 UR - https://doi.org/10.1016/j.prp.2009.05.003 DO - 10.1016/j.prp.2009.05.003 ID - Rausch2010 ER - TY - JOUR AU - Gomi, K. AU - Kitagawa, N. AU - Usui, Y. AU - Tanaka, M. AU - Yoshida, M. AU - Hirata, Y. PY - 2011 DA - 2011// TI - Papillary carcinoma with extensive squamous metaplasia arising from thyroglossal duct cyst in an 11-year-old girl: significance of differentiation from squamous cell carcinoma: a case report JO - J Pediatr Surg VL - 46 UR - https://doi.org/10.1016/j.jpedsurg.2010.10.030 DO - 10.1016/j.jpedsurg.2010.10.030 ID - Gomi2011 ER - TY - JOUR AU - Ahn, S. AU - Bae, G. E. AU - Kim, K. -. M. PY - 2015 DA - 2015// TI - Exuberant squamous metaplasia of the gastric mucosa in a patient with gastric adenocarcinoma JO - Diagn Pathol VL - 10 UR - https://doi.org/10.1186/s13000-015-0281-5 DO - 10.1186/s13000-015-0281-5 ID - Ahn2015 ER - TY - JOUR AU - Zou, M. AU - Toivanen, R. AU - Mitrofanova, A. AU - Floch, N. AU - Hayati, S. AU - Sun, Y. PY - 2017 DA - 2017// TI - Transdifferentiation as a mechanism of treatment resistance in a mouse model of castration-resistant prostate cancer JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.cd-16-1174 DO - 10.1158/2159-8290.cd-16-1174 ID - Zou2017 ER - TY - JOUR AU - Beltran, H. AU - Prandi, D. AU - Mosquera, J. M. AU - Benelli, M. AU - Puca, L. AU - Cyrta, J. PY - 2016 DA - 2016// TI - Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4045 DO - 10.1038/nm.4045 ID - Beltran2016 ER - TY - JOUR AU - Alvarez, M. J. AU - Subramaniam, P. S. AU - Tang, L. H. AU - Grunn, A. AU - Aburi, M. AU - Rieckhof, G. PY - 2018 DA - 2018// TI - A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors JO - Nat Genet VL - 50 UR - https://doi.org/10.1038/s41588-018-0138-4 DO - 10.1038/s41588-018-0138-4 ID - Alvarez2018 ER - TY - JOUR AU - Gong, L. AU - Yan, Q. AU - Zhang, Y. AU - Fang, X. AU - Liu, B. AU - Guan, X. PY - 2019 DA - 2019// TI - Cancer cell reprogramming: a promising therapy converting malignancy to benignity JO - Cancer Commun (London, England) VL - 39 UR - https://doi.org/10.1186/s40880-019-0393-5 DO - 10.1186/s40880-019-0393-5 ID - Gong2019 ER - TY - JOUR AU - Miura, K. AU - Mineta, H. AU - Yokota, N. AU - Tsutsui, Y. PY - 2001 DA - 2001// TI - Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy JO - Pathol Int VL - 51 UR - https://doi.org/10.1046/j.1440-1827.2001.01300.x DO - 10.1046/j.1440-1827.2001.01300.x ID - Miura2001 ER - TY - JOUR AU - Glass, T. AU - Cochrane, D. D. AU - Rassekh, S. R. AU - Goddard, K. AU - Hukin, J. PY - 2014 DA - 2014// TI - Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): a risk for secondary malignant transformation-a report of two cases JO - Child’s Nerv Syst VL - 30 UR - https://doi.org/10.1007/s00381-013-2295-1 DO - 10.1007/s00381-013-2295-1 ID - Glass2014 ER - TY - JOUR AU - Kesler, K. A. AU - Patel, J. B. AU - Kruter, L. E. AU - Birdas, T. J. AU - Rieger, K. M. AU - Okereke, I. C. PY - 2012 DA - 2012// TI - The “growing teratoma syndrome” in primary mediastinal nonseminomatous germ cell tumors: criteria based on current practice JO - J Thorac Cardiovasc Surg VL - 144 UR - https://doi.org/10.1016/j.jtcvs.2012.05.053 DO - 10.1016/j.jtcvs.2012.05.053 ID - Kesler2012 ER - TY - JOUR AU - Ghaouti, M. AU - Roquet, L. AU - Fazzalari, L. AU - Sibert, L. AU - Sabourin, J. C. PY - 2013 DA - 2013// TI - “Growing teratoma syndrome”: an unrecognized complication of treated germ cell tumors of the testis JO - Ann Pathol VL - 33 UR - https://doi.org/10.1016/j.annpat.2013.10.020 DO - 10.1016/j.annpat.2013.10.020 ID - Ghaouti2013 ER - TY - JOUR AU - Okamoto, I. AU - Araki, J. AU - Suto, R. AU - Shimada, M. AU - Nakagawa, K. AU - Fukuoka, M. PY - 2006 DA - 2006// TI - EGFR mutation in gefitinib-responsive small-cell lung cancer JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdj114 DO - 10.1093/annonc/mdj114 ID - Okamoto2006 ER - TY - JOUR AU - Popat, S. AU - Wotherspoon, A. AU - Nutting, C. M. AU - Gonzalez, D. AU - Nicholson, A. G. AU - O’Brien, M. PY - 2013 DA - 2013// TI - Transformation to “high grade” neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma JO - Lung Cancer (Amsterdam, Netherlands) VL - 80 UR - https://doi.org/10.1016/j.lungcan.2012.12.019 DO - 10.1016/j.lungcan.2012.12.019 ID - Popat2013 ER - TY - JOUR AU - Watanabe, S. AU - Sone, T. AU - Matsui, T. AU - Yamamura, K. AU - Tani, M. AU - Okazaki, A. PY - 2013 DA - 2013// TI - Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma JO - Lung Cancer (Amsterdam, Netherlands) VL - 82 UR - https://doi.org/10.1016/j.lungcan.2013.06.003 DO - 10.1016/j.lungcan.2013.06.003 ID - Watanabe2013 ER - TY - JOUR AU - Zhang, Y. AU - Li, X. Y. AU - Tang, Y. AU - Xu, Y. AU - Guo, W. H. AU - Li, Y. C. PY - 2013 DA - 2013// TI - Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma? JO - Lung Cancer (Amsterdam, Netherlands) VL - 81 UR - https://doi.org/10.1016/j.lungcan.2013.04.005 DO - 10.1016/j.lungcan.2013.04.005 ID - Zhang2013 ER - TY - JOUR AU - Suda, K. AU - Murakami, I. AU - Sakai, K. AU - Mizuuchi, H. AU - Shimizu, S. AU - Sato, K. PY - 2015 DA - 2015// TI - Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep14447 DO - 10.1038/srep14447 ID - Suda2015 ER - TY - JOUR AU - Hui, M. AU - Uppin, S. G. AU - Stalin, B. J. AU - Sadashivudu, G. PY - 2018 DA - 2018// TI - Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: report of a case with review of literature JO - Lung India VL - 35 UR - https://doi.org/10.4103/lungindia.lungindia_347_17 DO - 10.4103/lungindia.lungindia_347_17 ID - Hui2018 ER - TY - JOUR AU - Santoni-Rugiu, E. AU - Grauslund, M. AU - Melchior, L. C. AU - Costa, J. C. AU - Sorensen, J. B. AU - Urbanska, E. M. PY - 2017 DA - 2017// TI - Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation JO - Lung Cancer (Amsterdam, Netherlands) VL - 113 UR - https://doi.org/10.1016/j.lungcan.2017.08.024 DO - 10.1016/j.lungcan.2017.08.024 ID - Santoni-Rugiu2017 ER - TY - JOUR AU - Tokaca, N. AU - Wotherspoon, A. AU - Nicholson, A. G. AU - Fotiadis, N. AU - Thompson, L. AU - Popat, S. PY - 2017 DA - 2017// TI - Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer JO - Lung Cancer (Amsterdam, Netherlands) VL - 111 UR - https://doi.org/10.1016/j.lungcan.2017.07.012 DO - 10.1016/j.lungcan.2017.07.012 ID - Tokaca2017 ER - TY - JOUR AU - Wahab, A. AU - Kesari, K. AU - Chaudhary, S. AU - Khan, M. AU - Khan, H. AU - Smith, S. PY - 2017 DA - 2017// TI - Sequential occurrence of small cell and non-small lung cancer in a male patient: is it a transformation? JO - Cancer Biol Ther VL - 18 UR - https://doi.org/10.1080/15384047.2017.1394546 DO - 10.1080/15384047.2017.1394546 ID - Wahab2017 ER - TY - JOUR AU - Xu, Y. AU - Huang, Z. AU - Gong, L. AU - Fan, Y. PY - 2017 DA - 2017// TI - A case of resistance to tyrosine kinase inhibitor therapy: small cell carcinoma transformation concomitant with plasma-genotyped T790M positivity JO - Anticancer Drugs VL - 28 UR - https://doi.org/10.1097/cad.0000000000000540 DO - 10.1097/cad.0000000000000540 ID - Xu2017 ER - TY - JOUR AU - Riel, S. AU - Thunnissen, E. AU - Heideman, D. AU - Smit, E. F. AU - Biesma, B. PY - 2012 DA - 2012// TI - A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds525 DO - 10.1093/annonc/mds525 ID - Riel2012 ER - TY - JOUR AU - Kim, W. J. AU - Kim, S. AU - Choi, H. AU - Chang, J. AU - Shin, H. J. AU - Park, C. K. PY - 2015 DA - 2015// TI - Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor JO - Thorac Cancer VL - 6 UR - https://doi.org/10.1111/1759-7714.12217 DO - 10.1111/1759-7714.12217 ID - Kim2015 ER - TY - JOUR AU - Alì, G. AU - Bruno, R. AU - Giordano, M. AU - Prediletto, I. AU - Marconi, L. AU - Zupo, S. PY - 2016 DA - 2016// TI - Small cell lung cancer transformation and the T790M mutation: a case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma JO - Oncol Lett VL - 12 UR - https://doi.org/10.3892/ol.2016.5193 DO - 10.3892/ol.2016.5193 ID - Alì2016 ER - TY - JOUR AU - Alam, N. AU - Gustafson, K. S. AU - Ladanyi, M. AU - Zakowski, M. F. AU - Kapoor, A. AU - Truskinovsky, A. M. PY - 2010 DA - 2010// TI - Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung JO - Clin Lung Cancer VL - 11 UR - https://doi.org/10.3816/CLC.2010.n.046 DO - 10.3816/CLC.2010.n.046 ID - Alam2010 ER - TY - JOUR AU - Jiang, S. Y. AU - Zhao, J. AU - Wang, M. Z. AU - Huo, Z. AU - Zhang, J. AU - Zhong, W. PY - 2016 DA - 2016// TI - Small-cell lung cancer transformation in patients with pulmonary adenocarcinoma: a case report and review of literature JO - Medicine VL - 95 UR - https://doi.org/10.1097/md.0000000000002752 DO - 10.1097/md.0000000000002752 ID - Jiang2016 ER - TY - JOUR AU - Lin, Q. AU - Cai, G. P. AU - Yang, K. Y. AU - Yang, L. AU - Chen, C. S. AU - Li, Y. P. PY - 2016 DA - 2016// TI - Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2623-4 DO - 10.1186/s12885-016-2623-4 ID - Lin2016 ER - TY - JOUR AU - Ma, A. T. AU - Chan, W. K. AU - Ma, E. S. AU - Cheng, T. AU - Cheng, P. N. PY - 2012 DA - 2012// TI - Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung JO - Acta Oncol (Stockholm, Sweden) VL - 51 UR - https://doi.org/10.3109/0284186x.2011.636757 DO - 10.3109/0284186x.2011.636757 ID - Ma2012 ER - TY - JOUR AU - Kudo, K. AU - Ohyanagi, F. AU - Horiike, A. AU - Miyauchi, E. AU - Yanagitani, N. AU - Hoshi, R. PY - 2011 DA - 2011// TI - Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations JO - Lung Cancer (Amsterdam, Netherlands) VL - 74 UR - https://doi.org/10.1016/j.lungcan.2011.03.019 DO - 10.1016/j.lungcan.2011.03.019 ID - Kudo2011 ER - TY - JOUR AU - Liu, Y. PY - 2018 DA - 2018// TI - Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: a case report and literatures review JO - Cancer Biol Ther UR - https://doi.org/10.1080/15384047.2018.1435222 DO - 10.1080/15384047.2018.1435222 ID - Liu2018 ER - TY - JOUR AU - Hwang, K. E. AU - Jung, J. W. AU - Oh, S. J. AU - Park, M. J. AU - Shon, Y. J. AU - Choi, K. H. PY - 2015 DA - 2015// TI - Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin JO - Tumori VL - 101 UR - https://doi.org/10.5301/tj.5000276 DO - 10.5301/tj.5000276 ID - Hwang2015 ER - TY - JOUR AU - Morinaga, R. AU - Okamoto, I. AU - Furuta, K. AU - Kawano, Y. AU - Sekijima, M. AU - Dote, K. PY - 2007 DA - 2007// TI - Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation JO - Lung Cancer (Amsterdam, Netherlands) VL - 58 UR - https://doi.org/10.1016/j.lungcan.2007.05.014 DO - 10.1016/j.lungcan.2007.05.014 ID - Morinaga2007 ER - TY - JOUR AU - Le, T. AU - Sailors, J. AU - Oliver, D. H. AU - Mayer, M. AU - Hoskin, S. AU - Gerber, D. E. PY - 2017 DA - 2017// TI - Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition JO - Lung Cancer (Amsterdam, Netherlands) VL - 105 UR - https://doi.org/10.1016/j.lungcan.2017.01.005 DO - 10.1016/j.lungcan.2017.01.005 ID - Le2017 ER - TY - JOUR AU - Burkart, J. AU - Shilo, K. AU - Zhao, W. AU - Ozkan, E. AU - Ajam, A. AU - Otterson, G. A. PY - 2015 DA - 2015// TI - Metastatic squamous cell carcinoma component from an adenosquamous carcinoma of the lung with identical epidermal growth factor receptor mutations JO - Case Rep Pulmonol VL - 2015 UR - https://doi.org/10.1155/2015/283875 DO - 10.1155/2015/283875 ID - Burkart2015 ER - TY - JOUR AU - Haratani, K. AU - Hayashi, H. AU - Watanabe, S. AU - Kaneda, H. AU - Yoshida, T. AU - Takeda, M. PY - 2016 DA - 2016// TI - Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv495 DO - 10.1093/annonc/mdv495 ID - Haratani2016 ER - TY - JOUR AU - Hsieh, M. -. S. AU - Jhuang, J. -. Y. AU - Hua, S. -. F. AU - Chou, Y. -. H. PY - 2015 DA - 2015// TI - Histologic evolution from adenocarcinoma to squamous cell carcinoma after gefitinib treatment JO - Ann Thorac Surg VL - 99 UR - https://doi.org/10.1016/j.athoracsur.2014.02.075 DO - 10.1016/j.athoracsur.2014.02.075 ID - Hsieh2015 ER - TY - JOUR AU - Scher, K. S. AU - Saldivar, J. -. S. AU - Fishbein, M. AU - Marchevsky, A. AU - Reckamp, K. L. PY - 2013 DA - 2013// TI - EGFR-mutated lung cancer with T790M-acquired resistance in the brain and histologic transformation in the lung JO - J Natl Compr Cancer Netw VL - 11 UR - https://doi.org/10.6004/jnccn.2013.0126 DO - 10.6004/jnccn.2013.0126 ID - Scher2013 ER - TY - JOUR AU - Levin, P. A. AU - Mayer, M. AU - Hoskin, S. AU - Sailors, J. AU - Oliver, D. H. AU - Gerber, D. E. PY - 2015 DA - 2015// TI - Histologic transformation from adenocarcinoma to squamous cell carcinoma as a mechanism of resistance to EGFR inhibition JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000571 DO - 10.1097/JTO.0000000000000571 ID - Levin2015 ER - TY - JOUR AU - Clery, E. AU - Pisapia, P. AU - Feliciano, S. AU - Vigliar, E. AU - Marano, A. AU - Luca, C. PY - 2017 DA - 2017// TI - There is still a role for cytology in the ‘liquid biopsy’ era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression JO - J Clin Pathol VL - 70 UR - https://doi.org/10.1136/jclinpath-2017-204370 DO - 10.1136/jclinpath-2017-204370 ID - Clery2017 ER - TY - JOUR AU - Park, H. K. AU - Seo, Y. AU - Choi, Y. L. AU - Ahn, M. J. AU - Han, J. PY - 2017 DA - 2017// TI - Metastatic squamous cell carcinoma from lung adenocarcinoma after epidermal growth factor receptor tyrosine kinase inhibitor therapy JO - J Pathol Transl Med VL - 51 UR - https://doi.org/10.4132/jptm.2016.10.18 DO - 10.4132/jptm.2016.10.18 ID - Park2017 ER - TY - JOUR AU - Jukna, A. AU - Montanari, G. AU - Mengoli, M. C. AU - Cavazza, A. AU - Covi, M. AU - Barbieri, F. PY - 2016 DA - 2016// TI - Squamous cell carcinoma “transformation” concurrent with secondary T790M mutation in resistant EGFR-mutated adenocarcinomas JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.12.096 DO - 10.1016/j.jtho.2015.12.096 ID - Jukna2016 ER - TY - JOUR AU - Sato, M. AU - Matsui, A. AU - Shimoyama, Y. AU - Omote, N. AU - Morise, M. AU - Hase, T. PY - 2018 DA - 2018// TI - An EGFR-mutated lung adenocarcinoma undergoing squamous cell carcinoma transformation exhibited a durable response to afatinib JO - Intern Med VL - 57 UR - https://doi.org/10.2169/internalmedicine.0999-18 DO - 10.2169/internalmedicine.0999-18 ID - Sato2018 ER - TY - JOUR AU - Shinohara, S. AU - Ichiki, Y. AU - Fukuichi, Y. AU - Honda, Y. AU - Kanayama, M. AU - Taira, A. PY - 2018 DA - 2018// TI - Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer JO - J Thorac Dis VL - 10 UR - https://doi.org/10.21037/jtd.2018.06.83 DO - 10.21037/jtd.2018.06.83 ID - Shinohara2018 ER - TY - JOUR AU - Kuiper, J. L. AU - Ronden, M. I. AU - Becker, A. AU - Heideman, D. A. M. AU - Hengel, P. AU - Ylstra, B. PY - 2015 DA - 2015// TI - Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor JO - J Clin Pathol. VL - 68 UR - https://doi.org/10.1136/jclinpath-2015-202866 DO - 10.1136/jclinpath-2015-202866 ID - Kuiper2015 ER - TY - JOUR AU - Izumi, H. AU - Yamasaki, A. AU - Ueda, Y. AU - Sumikawa, T. AU - Maeta, H. AU - Nakamoto, S. PY - 2018 DA - 2018// TI - Squamous cell carcinoma transformation from EGFR-mutated lung adenocarcinoma: a case report and literature review JO - Clin Lung Cancer VL - 19 UR - https://doi.org/10.1016/j.cllc.2017.10.005 DO - 10.1016/j.cllc.2017.10.005 ID - Izumi2018 ER - TY - JOUR AU - Longo, L. AU - Mengoli, M. C. AU - Bertolini, F. AU - Bettelli, S. AU - Manfredini, S. AU - Rossi, G. PY - 2017 DA - 2017// TI - Synchronous occurrence of squamous-cell carcinoma “transformation” and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinoma JO - Lung Cancer (Amsterdam, Netherlands) VL - 103 UR - https://doi.org/10.1016/j.lungcan.2016.11.012 DO - 10.1016/j.lungcan.2016.11.012 ID - Longo2017 ER - TY - JOUR AU - Jay, G. AU - Jeffrey, P. G. AU - Weijie, M. AU - Ken, Y. AU - Elizabeth, H. M. AU - Megan, E. D. PY - 2019 DA - 2019// TI - Squamous cell transformation of primary lung adenocarcinoma in a patient with EML4-ALK fusion variant 5 refractory to ALK inhibitors JO - J Natl Compr Cancer Netw VL - 17 UR - https://doi.org/10.6004/jnccn.2019.7291 DO - 10.6004/jnccn.2019.7291 ID - Jay2019 ER - TY - JOUR AU - Park, S. AU - Han, J. AU - Sun, J. -. M. PY - 2019 DA - 2019// TI - Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor JO - Lung Cancer (Amsterdam, Netherlands) VL - 127 UR - https://doi.org/10.1016/j.lungcan.2018.11.027 DO - 10.1016/j.lungcan.2018.11.027 ID - Park2019 ER - TY - JOUR AU - Bugano, D. D. G. AU - Kalhor, N. AU - Zhang, J. AU - Neskey, M. AU - William, W. N. PY - 2015 DA - 2015// TI - Squamous-cell transformation in a patient with lung adenocarcinoma receiving erlotinib: co-occurrence with T790M mutation JO - Cancer Treat Commun VL - 4 UR - https://doi.org/10.1016/j.ctrc.2015.03.007 DO - 10.1016/j.ctrc.2015.03.007 ID - Bugano2015 ER - TY - JOUR AU - Hsu, C. -. L. AU - Chen, K. -. Y. AU - Kuo, S. -. W. AU - Chang, Y. -. L. PY - 2017 DA - 2017// TI - Histologic transformation in a patient with lung cancer treated with chemotherapy and pembrolizumab JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2017.02.006 DO - 10.1016/j.jtho.2017.02.006 ID - Hsu2017 ER -